The Birmingham executive who finally walks into a performance medicine consult usually has a normal fasting glucose. Normal A1c. A primary care doctor who has been saying everything looks fine for years. And a body that is not behaving like everything is fine.
The afternoon energy crash. The visceral weight that will not move despite training four days a week. The brain fog after lunch meetings. The slow recovery from workouts that used to feel easy. The cravings that arrive at predictable times and override discipline.
None of those symptoms appear on a standard metabolic panel. All of them point to the same underlying problem: insulin resistance, the quiet inflection point that most Birmingham executives cross years before any conventional test catches it.
What Insulin Resistance Actually Is
Insulin is the signal. Every cell in the body has insulin receptors waiting to hear it. When you eat a meal, the pancreas releases insulin, the receptors register the signal, and glucose moves out of the bloodstream and into muscle, liver, and fat cells.
Insulin resistance is what happens when the cells stop listening. The pancreas compensates by producing more insulin to force the signal through. Glucose still gets cleared. The standard fasting glucose test still looks normal. But the body is paying a metabolic tax to keep that number in range.
The tax accrues quietly for ten to fifteen years. Then it stops being quiet.
Why Birmingham Executives Get Missed on Standard Labs
Conventional medicine flags insulin resistance when fasting glucose climbs into prediabetic range. By that point, the pancreas has been producing high levels of insulin for a decade or more. The receptors have been hardening that entire time. Visceral fat has been accumulating. Cardiovascular risk has been climbing in parallel.
A Birmingham executive can spend a decade insulin resistant with a fasting glucose of 92 and an A1c of 5.5 and be told repeatedly that everything is normal.
It is not normal. It is the part of the trajectory that conventional ranges are not built to catch.
The Markers That Actually Measure Insulin Resistance
A functional medicine workup at Pro Fit High Performance Medicine looks at insulin resistance through markers that conventional labs treat as optional.
- Fasting insulin. The single most useful marker. Optimal sits under 5 µIU/mL. Most labs flag nothing under 25.
- HOMA-IR. A calculation that combines fasting insulin and fasting glucose. Optimal under 1.0. Standard reference ranges miss the inflection point entirely.
- Triglyceride to HDL ratio. Optimal under 2.0. A surrogate marker that shifts before glucose ever moves.
- Hemoglobin A1c. Optimal under 5.4. Conventional labs do not flag until 5.7.
- C-peptide. A marker of how much insulin the pancreas is actually producing.
Run together, these markers tell you where someone sits on the metabolic continuum years before standard testing would notice.
How the Pro Fit Performance Continuum Addresses Insulin Resistance
Insulin resistance is a downstream signal. It does not exist on its own. It sits on top of sleep debt, chronic stress, poor protein distribution, inadequate strength training, gut inflammation, and disrupted circadian rhythm. Treating it requires sequencing.
Pro Fit’s clinical framework, the Pro Fit Performance Continuum, handles insulin resistance across five phases.
- Phase 1: Assessment and Order Labs. Comprehensive insulin and metabolic panel, body composition, lifestyle baseline.
- Phase 2: Stabilization and Foundations. Sleep, stress, protein, training cadence, gut work. These are the upstream drivers and they get fixed before any advanced intervention.
- Phase 3: Optimization and Performance Medicine. Targeted nutrient repletion, hormone work where indicated, peptide protocols, and metabolic interventions like continuous glucose monitoring or GLP-1 therapy when the foundations cannot do the work alone.
- Phase 4: Monitoring and Adaptation. Quarterly labs, training response data, dose adjustments.
- Phase 5: Maintenance and Longevity Strategy. The long-tail protocol that holds the gains and protects cardiovascular and cognitive trajectory for the next thirty years.
The Five Drivers That Push Birmingham Executives Into Insulin Resistance
Insulin resistance does not arrive in a vacuum. It is engineered, slowly, by the conditions of an executive life. The drivers are predictable.
- Sleep debt. A single week of restricted sleep can drop insulin sensitivity by twenty to thirty percent in healthy adults. Most executives accept this state as baseline.
- Chronic cortisol output. Elevated cortisol blunts insulin signaling and pushes glucose into visceral fat. Stress is not a soft variable on a metabolic panel.
- Inadequate protein and strength training. Skeletal muscle is the largest glucose-disposal organ in the body. Losing muscle mass through underfeeding or undertraining shrinks the disposal site.
- Liquid calories and grazing. Frequent insulin spikes throughout the day, even from healthy-sounding sources, keep the pancreas in continuous output mode.
- Gut inflammation. Endotoxin translocation from a disrupted microbiome drives systemic insulin resistance independent of diet quality.
Any one of these is enough to start the drift. Most executives carry three or four.
What Insulin Resistance Looks Like in a High-Performing Body
Insulin resistance rarely announces itself as diabetes. In a Birmingham executive, it shows up as a constellation.
- Visceral fat that resists training adaptations
- Afternoon cognitive crashes that did not exist five years ago
- Slower recovery between hard sessions
- Cravings that escalate around 3 p.m. and 9 p.m.
- Poor sleep architecture, particularly fragmented deep sleep
- Rising blood pressure, often dismissed as stress
- Rising LDL particle count even with normal LDL-C
Each piece is treated separately by conventional medicine. The constellation, taken together, is one problem with a single name.
Why This Matters Before Forty
Insulin resistance is the upstream driver of most of what kills Birmingham executives slowly: cardiovascular disease, cognitive decline, metabolic dysfunction, and the gradual loss of physical capability. The interventions that reverse it are far more effective when started in the inflection-point years than after the diagnosis arrives.
It is also the marker that ties directly to the data executives are already starting to track. Continuous glucose monitoring data only becomes useful when paired with fasting insulin, HOMA-IR, and the rest of the panel. For more on the data layer, see our piece on continuous glucose monitors for non-diabetics.
The earlier this gets caught, the more leverage every intervention has.
Frequently Asked Questions
Can I be insulin resistant with normal fasting glucose?
Yes. The pancreas can hold glucose in range by producing more insulin for years before fasting glucose moves. Most Birmingham executives who screen positive for insulin resistance still have a normal fasting glucose on a standard lab.
How is insulin resistance reversed?
Strength training, protein distribution across the day, sleep architecture restoration, stress regulation, and targeted nutrient repletion. In stubborn cases, additional metabolic support, peptide protocols, or GLP-1 therapy may be appropriate. The order matters more than the intervention list.
Where should a Birmingham or Vestavia Hills executive start?
A comprehensive insulin and metabolic panel through a performance medicine practice. Pro Fit High Performance Medicine runs that workup, places clients in the appropriate phase of the Pro Fit Performance Continuum, and builds the protocol from there.
Next Step
Capability changes everything. If the metabolic signals have started to surface in your training, your cognition, or your recovery, the right next step is a structured assessment, not another general lab.
Book a Free Consult (Phase Placement) at profithpm.com.
